Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fleischhacker

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|April 16, 1998
Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapineB Sperner-Unterweger, I Czeipek, S Gaggl, et al.
Psychopharmacology|January 1, 1991
Characteristics of benzodiazepine long-term users: investigation of benzodiazepine consumers among pharmacy customersC Barnas, W W Fleischhacker, A B Whitworth, et al.
Acta Psychiatrica Scandinavica|September 11, 2018
Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTsK Kubo, W W Fleischhacker, T Suzuki, et al.
Biological Psychiatry|October 15, 1993
Effects of clozapine on hematopoiesis and the cytokine systemB Sperner-Unterweger, S Gaggl, W W Fleischhacker, et al.
The Journal of Clinical Psychiatry|July 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case reportC Barnas, H Zwierzina, M Hummer, et al.
Pharmacopsychiatry|June 23, 2017
Executive Dysfunctions Predict Self-Restricted Driving Habits in Elderly People with or without Alzheimer's DementiaIlsemarie Kurzthaler, Georg Kemmler, Michaela Defrancesco, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Risk factors for the development of neuroleptic induced akathisiaC H Miller, M Hummer, H Oberbauer, et al.
Acta Psychiatrica Scandinavica|September 18, 2007
Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophreniaA Hofer, M A Rettenbacher, M Edlinger, et al.
Alcoholism, Clinical and Experimental Research|August 1, 1993
Intravenous flunitrazepam in the treatment of alcohol withdrawal deliriumR Pycha, C Miller, C Barnas, et al.
Archiv Der Pharmazie|April 1, 1995
[Synthesis and pharmacodynamic activity of 2-(3-(2-phenylethyl)benzofuran-2-yl)-N-propyl-ethanamine]G Ecker, T Helml, W Fleischhacker, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
The British Journal of Psychiatry : the Journal of Mental Science|April 16, 1998
Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapineB Sperner-Unterweger, I Czeipek, S Gaggl, et al.
Psychopharmacology|January 1, 1991
Characteristics of benzodiazepine long-term users: investigation of benzodiazepine consumers among pharmacy customersC Barnas, W W Fleischhacker, A B Whitworth, et al.
Acta Psychiatrica Scandinavica|September 11, 2018
Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTsK Kubo, W W Fleischhacker, T Suzuki, et al.
Biological Psychiatry|October 15, 1993
Effects of clozapine on hematopoiesis and the cytokine systemB Sperner-Unterweger, S Gaggl, W W Fleischhacker, et al.
The Journal of Clinical Psychiatry|July 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case reportC Barnas, H Zwierzina, M Hummer, et al.
Pharmacopsychiatry|June 23, 2017
Executive Dysfunctions Predict Self-Restricted Driving Habits in Elderly People with or without Alzheimer's DementiaIlsemarie Kurzthaler, Georg Kemmler, Michaela Defrancesco, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Risk factors for the development of neuroleptic induced akathisiaC H Miller, M Hummer, H Oberbauer, et al.
Acta Psychiatrica Scandinavica|September 18, 2007
Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophreniaA Hofer, M A Rettenbacher, M Edlinger, et al.
Alcoholism, Clinical and Experimental Research|August 1, 1993
Intravenous flunitrazepam in the treatment of alcohol withdrawal deliriumR Pycha, C Miller, C Barnas, et al.
Archiv Der Pharmazie|April 1, 1995
[Synthesis and pharmacodynamic activity of 2-(3-(2-phenylethyl)benzofuran-2-yl)-N-propyl-ethanamine]G Ecker, T Helml, W Fleischhacker, et al.
Pageof 15